Compound index

Steroid Hormones

Testosterone cypionate

FDA-approved for specific indicationsFDA-approved

Last reviewed: 2026-11-19

Evidence status & limitations

Approved replacement indications concern documented hypogonadal disorders, not general performance or aging.

Regulatory status

FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.

  • Depo-Testosterone · Hormone Therapy

    Replacement in males with conditions associated with deficiency or absence of endogenous testosterone, under labeled diagnostic criteria.

    Authoritative label record

Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

WADA prohibited status: current list and context

Known risks & open questions

Blood-cell elevation, blood-pressure changes, infertility and endocrine suppression are documented concerns.

Key sources

Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.

Related compounds

  • Progesterone

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

Related glossary terms